Of 16,732 patients with metastatic prostate cancer who died after being diagnosed between 2000 and 2016, nearly 17 percent died from other causes, according to a study published Aug. 5 in JAMA Network ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...

While prostate cancer recurrence is a major cause of death in patients receiving localized treatment, there are other significant causes of mortality. While prostate cancer progression or recurrence ...

Prostate cancer stands as the second most commonly diagnosed cancer in men worldwide, following lung cancer, according to the American Cancer Society. Alarming projections by the National Cancer ...

Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published in Annals of Internal Medicine indicated.“We have developed a tool that can ...